Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Jan. 21, 2023
Despite
advances
in
early
detection
and
therapies,
cancer
is
still
one
of
the
most
common
causes
death
worldwide.
Since
each
tumor
unique,
there
a
need
to
implement
personalized
care
develop
robust
tools
for
monitoring
treatment
response
assess
drug
efficacy
prevent
disease
relapse.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: March 29, 2021
Abstract
Currently,
pyroptosis
has
received
more
and
attention
because
of
its
association
with
innate
immunity
disease.
The
research
scope
expanded
the
discovery
gasdermin
family.
A
great
deal
evidence
shows
that
can
affect
development
tumors.
relationship
between
tumors
is
diverse
in
different
tissues
genetic
backgrounds.
In
this
review,
we
provide
basic
knowledge
pyroptosis,
explain
tumors,
focus
on
significance
tumor
treatment.
addition,
further
summarize
possibility
as
a
potential
treatment
strategy
describe
side
effects
radiotherapy
chemotherapy
caused
by
pyroptosis.
brief,
double-edged
sword
for
rational
use
dual
effect
will
help
us
explore
formation
ideas
patients
to
develop
new
drugs
based
Journal of Hematology & Oncology,
Journal Year:
2020,
Volume and Issue:
13(1)
Published: Aug. 10, 2020
Abstract
In
recent
years,
cancer
immunotherapy
based
on
immune
checkpoint
inhibitors
(ICIs)
has
achieved
considerable
success
in
the
clinic.
However,
ICIs
are
significantly
limited
by
fact
that
only
one
third
of
patients
with
most
types
respond
to
these
agents.
The
induction
cell
death
mechanisms
other
than
apoptosis
gradually
emerged
as
a
new
treatment
strategy
because
tumors
harbor
innate
resistance
apoptosis.
date,
possibility
combining
two
modalities
not
been
discussed
systematically.
Recently,
few
studies
revealed
crosstalk
between
distinct
and
antitumor
immunity.
pyroptosis,
ferroptosis,
necroptosis
combined
showed
synergistically
enhanced
activity,
even
ICI-resistant
tumors.
Immunotherapy-activated
CD8+
T
cells
traditionally
believed
induce
tumor
via
following
main
pathways:
(i)
perforin-granzyme
(ii)
Fas-FasL.
identified
mechanism
which
suppress
growth
inducing
ferroptosis
provoked
review
relationship
system
activation.
Hence,
this
review,
we
summarize
knowledge
reciprocal
interaction
immunity
mechanisms,
particularly
necroptosis,
three
potentially
novel
immunogenic
death.
Because
evidence
is
derived
from
using
animal
models,
also
reviewed
related
bioinformatics
data
available
for
human
tissues
public
databases,
partially
confirmed
presence
interactions
activation
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: June 20, 2022
Abstract
In
recent
years,
immunotherapy
represented
by
immune
checkpoint
inhibitors
(ICIs)
has
led
to
unprecedented
breakthroughs
in
cancer
treatment.
However,
the
fact
that
many
tumors
respond
poorly
or
even
not
ICIs,
partly
caused
absence
of
tumor-infiltrating
lymphocytes
(TILs),
significantly
limits
application
ICIs.
Converting
these
“cold”
into
“hot”
may
ICIs
is
an
unsolved
question
immunotherapy.
Since
it
a
general
characteristic
cancers
resist
apoptosis,
induction
non-apoptotic
regulated
cell
death
(RCD)
emerging
as
new
treatment
strategy.
Recently,
several
studies
have
revealed
interaction
between
RCD
and
antitumor
immunity.
Specifically,
autophagy,
ferroptosis,
pyroptosis,
necroptosis
exhibit
synergistic
responses
while
possibly
exerting
inhibitory
effects
on
responses.
Thus,
targeted
therapies
(inducers
inhibitors)
against
combination
with
exert
potent
activity,
resistant
This
review
summarizes
multilevel
relationship
immunity
RCD,
including
necroptosis,
potential
targeting
improve
efficacy
malignancy.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: June 8, 2023
Abstract
Aging
is
characterized
by
systemic
chronic
inflammation,
which
accompanied
cellular
senescence,
immunosenescence,
organ
dysfunction,
and
age-related
diseases.
Given
the
multidimensional
complexity
of
aging,
there
an
urgent
need
for
a
systematic
organization
inflammaging
through
dimensionality
reduction.
Factors
secreted
senescent
cells,
known
as
senescence-associated
secretory
phenotype
(SASP),
promote
inflammation
can
induce
senescence
in
normal
cells.
At
same
time,
accelerates
immune
resulting
weakened
function
inability
to
clear
cells
inflammatory
factors,
creates
vicious
cycle
senescence.
Persistently
elevated
levels
organs
such
bone
marrow,
liver,
lungs
cannot
be
eliminated
leading
damage
aging-related
Therefore,
has
been
recognized
endogenous
factor
elimination
could
potential
strategy
anti-aging.
Here
we
discuss
at
molecular,
cellular,
organ,
disease
levels,
review
current
aging
models,
implications
cutting-edge
single
cell
technologies,
well
anti-aging
strategies.
Since
preventing
alleviating
diseases
improving
overall
quality
life
are
ultimate
goals
research,
our
highlights
critical
features
mechanisms
along
with
latest
developments
future
directions
providing
theoretical
foundation
novel
practical
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: Dec. 8, 2022
Abstract
Many
types
of
human
cells
self-destruct
to
maintain
biological
homeostasis
and
defend
the
body
against
pathogenic
substances.
This
process,
called
regulated
cell
death
(RCD),
is
important
for
various
activities,
including
clearance
aberrant
cells.
Thus,
RCD
pathways
represented
by
apoptosis
have
increased
in
importance
as
a
target
development
cancer
medications
recent
years.
However,
because
tumor
show
avoidance
apoptosis,
which
causes
treatment
resistance
recurrence,
numerous
studies
been
devoted
alternative
mortality
processes,
namely
necroptosis,
pyroptosis,
ferroptosis,
cuproptosis;
these
modalities
extensively
studied
shown
be
crucial
therapy
effectiveness.
Furthermore,
evidence
suggests
that
undergoing
may
alter
immunogenicity
microenvironment
(TME)
some
extent,
rendering
it
more
suitable
inhibiting
progression
metastasis.
In
addition,
other
components
TME
undergo
abovementioned
forms
induce
immune
attacks
on
cells,
resulting
enhanced
antitumor
responses.
Hence,
this
review
discusses
molecular
processes
features
cuproptosis
effects
novel
proliferation
Importantly,
introduces
complex
affect
biology.
It
also
summarizes
potential
agents
nanoparticles
or
inhibit
their
therapeutic
based
from
vivo
vitro
reports
clinical
trials
inducers
evaluated
treatments
patients.
Lastly,
we
summarized
impact
modulating
drug
advantages
adding
modulators
over
conventional
treatments.
Cell Death Discovery,
Journal Year:
2020,
Volume and Issue:
6(1)
Published: Oct. 28, 2020
Abstract
Apoptosis
has
long
been
recognized
as
a
mechanism
that
kills
the
cancer
cells
by
cytotoxic
drugs.
In
recent
years,
studies
have
proved
pyroptosis
can
also
shrink
tumors
and
inhibit
proliferation.
Both
apoptosis
are
caspase-dependent
programmed
cell
death
pathways.
Cysteinyl
aspartate
specific
proteinase-3
(Caspase-3)
is
common
key
protein
in
pathways,
when
activated,
expression
level
of
tumor
suppressor
gene
Gasdermin
E
(GSDME)
determines
death.
When
GSDME
highly
expressed,
active
caspase-3
cuts
it
releases
N-terminal
domain
to
punch
holes
membrane,
resulting
swelling,
rupture,
low,
will
lead
classical
death,
which
apoptosis.
More
interestingly,
researchers
found
be
located
upstream
caspase-3,
connecting
extrinsic,
intrinsic
apoptotic
Then,
promoting
activation,
forming
self-amplifying
feed-forward
loop.
GSDME-mediated
correlated
with
side
effects
chemotherapy
anti-tumor
immunity.
This
article
mainly
reviews
caspase-3/GSDME
signal
pathway
switch
between
cancer,
provide
new
strategies
targets
for
treatment.
Cell Death Discovery,
Journal Year:
2021,
Volume and Issue:
7(1)
Published: April 7, 2021
Abstract
Ovarian
cancer
(OC)
is
a
highly
malignant
gynaecological
tumour
that
has
very
poor
prognosis.
Pyroptosis
been
demonstrated
in
recent
years
to
be
an
inflammatory
form
of
programmed
cell
death.
However,
the
expression
pyroptosis-related
genes
OC
and
their
correlations
with
prognosis
remain
unclear.
In
this
study,
we
identified
31
pyroptosis
regulators
were
differentially
expressed
between
normal
ovarian
tissues.
Based
on
these
(DEGs),
all
cases
could
divided
into
two
subtypes.
The
prognostic
value
each
gene
for
survival
was
evaluated
construct
multigene
signature
using
Cancer
Genome
Atlas
(TCGA)
cohort.
By
applying
least
absolute
shrinkage
selection
operator
(LASSO)
Cox
regression
method,
7-gene
built
classified
patients
TCGA
cohort
low-
or
high-risk
group.
low-risk
group
showed
significantly
higher
possibilities
than
those
(
P
<
0.001).
Utilizing
median
risk
score
from
cohort,
Gene
Expression
Omnibus
(GEO)
subgroups,
had
increased
overall
(OS)
time
=
0.014).
Combined
clinical
characteristics,
found
independent
factor
predicting
OS
patients.
ontology
(GO)
Kyoto
Encylopedia
Genes
Genomes
(KEGG)
analyses
indicated
immune-related
enriched
immune
status
decreased
conclusion,
play
important
roles
immunity
can
used
predict
OCs.
Cells,
Journal Year:
2023,
Volume and Issue:
12(4), P. 659 - 659
Published: Feb. 19, 2023
Doxorubicin
(DOX)
constitutes
the
major
constituent
of
anti-cancer
treatment
regimens
currently
in
clinical
use.
However,
precise
mechanisms
DOX’s
action
are
not
fully
understood.
Emerging
evidence
points
to
pleiotropic
anticancer
activity
DOX,
including
its
contribution
DNA
damage,
reactive
oxygen
species
(ROS)
production,
apoptosis,
senescence,
autophagy,
ferroptosis,
and
pyroptosis
induction,
as
well
immunomodulatory
role.
This
review
aims
collect
information
on
DOX
influence
anti-tumor
immune
response,
providing
a
rationale
behind
importance
modern
cancer
therapy.